First Eagle Investment Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-70,000
Closed -$2.72M 399
2013
Q4
$2.72M Buy
70,000
+20,000
+40% +$778K 0.01% 181
2013
Q3
$2.27M Hold
50,000
0.01% 198
2013
Q2
$2.46M Buy
+50,000
New +$2.46M 0.01% 216